The Dipharma Group is a global CDMO and one of the leading family-owned manufacturers of Active Pharmaceutical Ingredients and Intermediates, having a portfolio of more than 40 products, with Drug Master Files lodged worldwide. Dipharma serves top ranking pharmaceutical companies in Europe, U.S.A. and Japan. Supported by a fully equipped R&D Centers, its core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenation, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes.
| Website | http://www.dipharma.com/ |
| Revenue | $43.7 million |
| Employees | 351 (248 on RocketReach) |
| Founded | 1949 |
| Phone | (269) 488-8239 |
| Fax | (269) 488-8490 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Web Rank | 7 Million |
| Keywords | Active Pharmaceutical Ingredients, Api Manufacturer, Pharmaceutical Manufacturing, Api Production, Cdmo, Contract Development And Manufacturing, Drug Substance Manufacturing, Contract Manufacturing Organization, Pharmaceutical Intermediates, Pharmaceutical Development, Cgmp Manufacturing, Custom Synthesis, Drug Production, Manufacturing |
| Competitors | Boehringer Ingelheim, Catalent Pharma Solutions, Hikma Pharmaceuticals, Lonza, Sandoz, Recipharm, Dr. Reddy's Laboratories, Aenova Group, Aptar Pharma, FAMAR FUEGUINA SA +36 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Dipharma Francis S.r.l employee's phone or email?
The Dipharma Francis S.r.l annual revenue was $43.7 million in 2026.
Chiara Mauri is the CFO of Dipharma Francis S.r.l.
248 people are employed at Dipharma Francis S.r.l.
The NAICS codes for Dipharma Francis S.r.l are [32541, 3254, 32, 325].
The SIC codes for Dipharma Francis S.r.l are [283, 28].